SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : AMERICAN BIOMED, Minimally Invasive Technology (ABMI)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bill Fortune III who wrote (895)5/21/1998 5:58:00 PM
From: Ray Tarke  Read Replies (2) of 2887
 
One of many Revolutionary Products - The OmniCath Atherectomy Catheter.

The OmniCath is an atherectomy catheter, designed to allow physicians
to remove atherosclerotic plaque from obstructed blood vessels throughout the
body, enlarging the narrowed vessel openings and thereby restoring normal blood
flow. The Company is developing the OmniCath with catheter shafts of several
different diameters for use in coronary arteries which feed the heart (5.8 to 7
French) and in peripheral arteries in the abdomen, groin and legs (7 French and
8 French). "French" is a measure of diameter, one French is equivalent to 1/3rd
of a millimeter. The OmniCath is self-contained and disposable and is powered
by a small battery pack and motor assembly in the handle. Connected to the
handle is the catheter shaft which will vary in length depending on the distance
needed from insertion to the treatment site. The weight of the OmniCath is
approximately 11 ounces.

The OmniCath's shaft has a side-window and a small rotating cylindrical
blade near its distal end (the end of the catheter or farthest part of the
catheter which is inserted into the body). At the surface opposite the
side-window are two deflector wires which, when advanced against the arterial
wall opposite the plaque using controls in the handle, stabilize the catheter
shaft and allow the window to cover a larger volume of the plaque, compressing
it into the path of the rotating blade. Once the deflector wires are
engaged and the side window is in position, using controls on the OmniCath
handle, the rotating blade can be advanced and retracted across the side-window
at approximately 11,000 RPM to shave the atherosclerotic plaque from the
interior surface of the vessel walls. The blade does not come into contact with
the non-diseased arterial walls during the atherectomy procedure. The shaved
plaque is aspirated into an annular space in the catheter and evacuated through
a removal port at the proximal end of the catheter (the end at the OmniCath
handle) via a vacuum system. This enables the excised plaque to be collected and
examined while the atherectomy is taking place. There is very little loss of
blood during the procedure as the OmniCath is designed to restrict the amount
of blood which enters the catheter system. Further, the blockage of blood
circulation by an inflated balloon, which often occurs in balloon angioplasty,
does not occur in a procedure using the OmniCath. The deflectable system
which holds the catheter in place is designed to allow for continuous blood
flow. This allows more time to complete a procedure although a procedure using
the OmniCath should generally require less time than a procedure utilizing
multiple balloon inflations to break up the plaque. As opposed to balloon
angioplasty, which cracks and displaces plaque, the shaving mechanism of the
OmniCath removes plaque and is designed to leave the artery clean and smooth,
free of fissures, ruptures, and flaps.

Overall, the OmniCath is designed for ease of use and provides the
physician with the capability to multiple lesion atherectomy procedures with a
single placement as opposed to the multiple placements often required with
balloon angioplasty and competitive atherectomy devices. The OmniCath's
features, including its lightweight and compact construction are designed to
provide a competitive advantage over existing atherectomy catheters.

The news Today !

biz.yahoo.com

This news is Fantastic and how many in the medical arena such as J&J and many other would love to have this in there portfolio.

Look at the String of great news one after another this company could be the "Deal of the Century" at this price you can make yourself rich, but the price is not going stay low for long.

I am buying and waiting for this Baby ... brings in the Pot of Gold !

Regards,
R.T

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext